GSK-1520489A
CAS No. 1042433-41-9
GSK-1520489A ( —— )
Catalog No. M28990 CAS No. 1042433-41-9
GSK-1520489A is an active PKMYT1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 192 | Get Quote |
|
10MG | 312 | Get Quote |
|
25MG | 530 | Get Quote |
|
50MG | 758 | Get Quote |
|
100MG | 1044 | Get Quote |
|
500MG | 2097 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-1520489A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-1520489A is an active PKMYT1 inhibitor.
-
DescriptionGSK-1520489A is an active PKMYT1 inhibitor.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMCT4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1042433-41-9
-
Formula Weight538.5
-
Molecular FormulaC21H23N4O7PS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)S(c1cc2c(Nc(cc3)cc4c3scn4)ncnc2cc1OCCOP(O)(O)=O)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cluntun AA, et.al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 2021 Mar 2;33(3):629-648.e10.
molnova catalog
related products
-
PRX-08066 Maleic aci...
PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2.
-
Temoporfin
Temoporfin used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck.
-
Methylstat
Methylstat is a methyl ester prodrug of a Jumonji C domain-containing histone demethylase (JMJD) inhibitor that has favorable cell permeability.